Search

Your search keyword '"Maria, Ruggero"' showing total 1,022 results

Search Constraints

Start Over You searched for: Author "Maria, Ruggero" Remove constraint Author: "Maria, Ruggero"
1,022 results on '"Maria, Ruggero"'

Search Results

1. The 1+Million Genomes Minimal Dataset for Cancer

2. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres

3. Apoptotic cell death in disease—Current understanding of the NCCD 2023

5. Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients

6. L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients

7. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems

10. Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

11. Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

12. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer

13. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

14. A real-time integrated framework to support clinical decision making for covid-19 patients

15. Advancements in 3D In Vitro Models for Colorectal Cancer.

16. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

17. KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy

18. Demographic Analysis of Cancer Research Priorities and Treatment Correlations

19. Uracil‐ and Pyridine‐Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem Cells

20. CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin

21. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51

22. Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

23. The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

24. Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery

26. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma

27. Apoptotic cell death in disease—Current understanding of the NCCD 2023

28. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant

29. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer

30. Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy.

31. Mobilising Collaboration among Stakeholders to Optimise the Growing Potential of Data for Tackling Cancer

32. The Minimal Dataset for Cancer of the 1+Million Genomes Initiative

33. OMICS AND PROGNSTIC MARKERS

34. Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

35. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection

37. A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?

38. A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

43. Supplementary Figure 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

50. Supplementary Figure Legends from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

Catalog

Books, media, physical & digital resources